We are live on
!
Find out more
Protagonist Therapeutics
PTGX
PTGX
150.53
USD
-0.97
0.64%
At close
Updated
Aug 27, 2:49 PM EDT
Pre-market
After hours
1 day
-0.64%
5 days
-1.03%
1 month
11.04%
3 months
47.28%
6 months
63.48%
Year to date
72.67%
1 year
145.04%
5 years
214.46%
10 years
1,317.42%
New
Increased
Maintained
Reduced
Closed
Mega AUM
Over $200B
Large AUM
$10B to $200B
Mid AUM
$2B to $10B
Small AUM
$250M to $2B
Micro AUM
Under $250M
Less than 10%
Less than 20%
Less than 40%
Less than 60%
Less than 80%
| # | Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|---|
| 176 |
BCM
176
Bayesian Capital Management
Brooklyn,
New York
| – | -$254K | -9,211 | Closed |
|
| 177 |
177
Verition Fund Management
Greenwich,
Connecticut
| – | -$254K | -9,210 | Closed |
|
| 178 |
AIM
178
Aigen Investment Management
New York
| – | -$208K | -7,527 | Closed |
|
| 179 |
NA
179
NewEdge Advisors
New Orleans,
Louisiana
| – | -$89.2K | -3,230 | Closed |
|
| 180 |
LSA
180
Leonteq Securities AG
Zurich,
Switzerland
| – | -$13K | -470 | Closed |
|
| 181 |
S
181
SignatureFD
Atlanta,
Georgia
| – | -$911 | -33 | Closed |
|
| 182 |
C
182
Covestor
London,
United Kingdom
| – | -$19 | -1 | -17% |
|